KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Income towards Parent Company: 2009-2014

Historic Income towards Parent Company for Biocryst Pharmaceuticals (BCRX) over the last 6 years, with Dec 2014 value amounting to -$50.7 million.

  • Biocryst Pharmaceuticals' Income towards Parent Company fell 11.36% to -$14.3 million in Q3 2015 from the same period last year, while for Sep 2015 it was -$42.2 million, marking a year-over-year decrease of 0.88%. This contributed to the annual value of -$50.7 million for FY2014, which is 43.14% down from last year.
  • Latest data reveals that Biocryst Pharmaceuticals reported Income towards Parent Company of -$50.7 million as of FY2014, which was down 43.14% from -$35.4 million recorded in FY2013.
  • Biocryst Pharmaceuticals' Income towards Parent Company's 5-year high stood at -$33.9 million during FY2010, with a 5-year trough of -$52.9 million in FY2011.
  • Moreover, its 3-year median value for Income towards Parent Company was -$38.3 million (2012), whereas its average is -$41.5 million.
  • In the last 5 years, Biocryst Pharmaceuticals' Income towards Parent Company crashed by 151.68% in 2010 and then increased by 27.60% in 2012.
  • Yearly analysis of 5 years shows Biocryst Pharmaceuticals' Income towards Parent Company stood at -$33.9 million in 2010, then tumbled by 56.41% to -$52.9 million in 2011, then climbed by 27.60% to -$38.3 million in 2012, then grew by 7.64% to -$35.4 million in 2013, then slumped by 43.14% to -$50.7 million in 2014.